Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Expert Rev Mol Diagn. 2019 Sep 10;20(2):123–125. doi: 10.1080/14737159.2019.1665507

Figure 1. An integrated three dimensional multimodality work flow to evaluate new glycomic and extracellular matrix biomarker candidates for prostate cancer.

Figure 1.

A. Representative pre-prostatectomy MRI images for T2W (T2 Weighted Image) and DWI (Diffusion-weighted image). B. A representative 3D-mold from mpMRI used for preparing prostatectomy tissue co-registered with mpMRI coordinates. C. Gross pathology and standard H&E stained tissue section, with two representative MALDI-IMS images of tumor and stroma localized N-glycans and collagenase derived ECM peptides in the same tissue slice.